Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 4.30% is 48% below its 5-year average of 8.21%, near the low end of its 5-year range (2.87%–11.86%).
5.39% below its 12-month average of 4.54%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
4.30%
RETURN ON ASSETS (ROA) AVG TTM
4.54%
RETURN ON ASSETS (ROA) AVG 3Y
7.94%
RETURN ON ASSETS (ROA) AVG 5Y
8.21%
RETURN ON ASSETS (ROA) AVG 10Y
7.87%
RETURN ON ASSETS (ROA) AVG 15Y
10.55%
RETURN ON ASSETS (ROA) AVG 20Y
12.98%
CURRENT VS TTM AVG
-5.39%
CURRENT VS 3Y AVG
-45.84%
CURRENT VS 5Y AVG
-47.64%
CURRENT VS 10Y AVG
-45.37%
CURRENT VS 15Y AVG
-59.26%
CURRENT VS 20Y AVG
-66.86%
SECTOR MEDIAN · HEALTHCARE
4.94%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-12.96%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.30B
Return on Assets (ROA)
4.30%
TTM Avg
4.54%
3Y Avg
7.94%
5Y Avg
8.21%
Market Cap
$10.21B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$12.39B
Return on Assets (ROA)
6444.45%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$10.16B
Return on Assets (ROA)
3.49%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$10.15B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.02B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$9.76B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$12.91B
Return on Assets (ROA)
1.97%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.30B | 4.30% | 4.54% | 7.94% | 8.21% |
| DaVita Inc. (DVA)vs › | $11.45B | 4.76% | 4.84% | 4.27% | 4.56% |
| Universal Health Services, Inc. (UHS)vs › | $10.21B | 9.58% | 8.61% | 6.84% | 6.99% |
| Align Technology, Inc. (ALGN)vs › | $12.39B | 6444.45% | 6.68% | 6.69% | 12.75% |
| Henry Schein, Inc. (HSIC)vs › | $10.16B | 3.49% | 3.68% | 4.39% | 5.01% |
| Molina Healthcare, Inc. (MOH)vs › | $10.15B | -0.04% | 5.29% | 6.08% | 6.13% |
| Insulet Corp. (PODD)vs › | $10.02B | 11.86% | 10.65% | 7.37% | 5.11% |
| Tempus AI, Inc. (TEM)vs › | $9.76B | -10.75% | -43.49% | -42.71% | -41.26% |
| Revvity, Inc. (RVTY)vs › | $12.91B | 1.97% | 2.19% | 1.89% | 3.83% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.59B | 2.17% | -6.26% | -11.14% | 1.46% |
ROA
4.3%
ROE
5.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | 2.87% |
| 2024-06-30 | 6.22% |
| 2023-06-30 | 10.81% |
| 2022-06-30 | 11.86% |
| 2021-06-30 | 6.20% |
| 2020-06-30 | 11.31% |
| 2019-06-30 | 5.10% |
| 2018-06-30 | 7.87% |
| 2017-06-30 | 4.96% |
| 2016-06-30 | 9.25% |
| 2015-06-30 | 10.13% |
| 2014-06-30 | 12.86% |
| 2013-06-30 | 14.47% |
| 2012-06-30 | 15.62% |
| 2011-06-30 | 18.18% |
| 2010-06-30 | 21.16% |
| 2009-06-30 | 22.30% |
| 2008-06-30 | 20.41% |
| 2007-06-30 | 18.71% |
| 2006-06-30 | 19.80% |
| 2005-06-30 | 22.40% |
| 2004-06-30 | 16.26% |
| 2003-06-30 | 17.24% |
| 2002-06-30 | 11.39% |
| 2001-06-30 | 15.80% |
| 2000-06-30 | 14.73% |
| 1999-06-30 | 13.49% |
| 1998-06-30 | 20.85% |
| 1997-06-30 | 20.22% |
| 1996-06-30 | 19.37% |
